aap Implantate AG (aap) has reported preliminary sales of EUR31.2 million for the fiscal 2008, up 11%, compared with the preliminary sales of EUR28 million in the previous year-end. It reported has reported preliminary sales of EUR7.1 million for the fourth quarter of fiscal 2008, down 24%, compared with the preliminary sales of EUR9.4 million in the year ago quarter.
In 2008, the group companies active in the field of medical biomaterials („aap bio implants group“), achieved sales of EUR19.4 million (previous year: EUR18.8 million, + 3%). This development is based on the considerably cautious customers’ order behavior (reduction of inventories) as well as delays in planned approvals of new products.
The Berlin based trauma & orthopaedics division of the company reached for the full financial year 2008 a strong organic sales increase of 28% to EUR11.8 million (previous year: EUR9.2 million).
The full year an annual financial statement 2008 is planned for April 17, 2009.